Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Reproduction, Fertility, and Development
|
March 10, 2012
Epidermal growth factor upregulates endometrial CYR61 expression via activation of the JAK2/STAT3 pathway
Rebecca Klein, Simone Stiller, Isabella Gashaw
Journal of Molecular Medicine (Berlin, Germany)
|
May 16, 2024
Non-invasive biomarkers prognostic of decompensation events in NASH cirrhosis: a systematic literature review
Mattia Amoroso, Salvador Augustin, Sven Moosmang, et al.
Drug Discovery Today
|
December 14, 2011
What makes a good drug target?
Isabella Gashaw, Peter Ellinghaus, Anette Sommer, et al.
Drug Discovery Today
|
September 28, 2011
What makes a good drug target?
Isabella Gashaw, Peter Ellinghaus, Anette Sommer, et al.
Endocrinology
|
January 19, 2008
Premenstrual regulation of the pro-angiogenic factor CYR61 in human endometrium
Isabella Gashaw, Simone Stiller, Carsten Böing, et al.
Reproductive Biology and Endocrinology : RB&E
|
September 9, 2008
TLR3 and TLR4 expression in healthy and diseased human endometrium
Svenja Allhorn, Carsten Böing, Andrea A Koch, et al.
Biology of Reproduction
|
February 17, 2006
Induced endometriosis in the baboon (Papio anubis) increases the expression of the proangiogenic factor CYR61 (CCN1) in eutopic and ectopic endometria
Isabella Gashaw, Julie M Hastings, Kevin S Jackson, et al.
Neoplasia (New York, N.Y.)
|
June 22, 2005
Differential expression of IGF components and insulin receptor isoforms in human seminoma versus normal testicular tissue
Tanja Pascale Neuvians, Isabella Gashaw, Andrea Hasenfus, et al.
Plos One
|
August 11, 2012
Granulocytes and vascularization regulate uterine bleeding and tissue remodeling in a mouse menstruation model
Astrid Menning, Alexander Walter, Marion Rudolph, et al.
British Journal of Clinical Pharmacology
|
April 19, 2022
First-in-human study of eliapixant (BAY 1817080), a highly selective P2X3 receptor antagonist: Tolerability, safety and pharmacokinetics
Stefan Klein, Isabella Gashaw, Sybille Baumann, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Reproduction, Fertility, and Development
|
March 10, 2012
Epidermal growth factor upregulates endometrial CYR61 expression via activation of the JAK2/STAT3 pathway
Rebecca Klein, Simone Stiller, Isabella Gashaw
Journal of Molecular Medicine (Berlin, Germany)
|
May 16, 2024
Non-invasive biomarkers prognostic of decompensation events in NASH cirrhosis: a systematic literature review
Mattia Amoroso, Salvador Augustin, Sven Moosmang, et al.
Drug Discovery Today
|
December 14, 2011
What makes a good drug target?
Isabella Gashaw, Peter Ellinghaus, Anette Sommer, et al.
Drug Discovery Today
|
September 28, 2011
What makes a good drug target?
Isabella Gashaw, Peter Ellinghaus, Anette Sommer, et al.
Endocrinology
|
January 19, 2008
Premenstrual regulation of the pro-angiogenic factor CYR61 in human endometrium
Isabella Gashaw, Simone Stiller, Carsten Böing, et al.
Reproductive Biology and Endocrinology : RB&E
|
September 9, 2008
TLR3 and TLR4 expression in healthy and diseased human endometrium
Svenja Allhorn, Carsten Böing, Andrea A Koch, et al.
Biology of Reproduction
|
February 17, 2006
Induced endometriosis in the baboon (Papio anubis) increases the expression of the proangiogenic factor CYR61 (CCN1) in eutopic and ectopic endometria
Isabella Gashaw, Julie M Hastings, Kevin S Jackson, et al.
Neoplasia (New York, N.Y.)
|
June 22, 2005
Differential expression of IGF components and insulin receptor isoforms in human seminoma versus normal testicular tissue
Tanja Pascale Neuvians, Isabella Gashaw, Andrea Hasenfus, et al.
Plos One
|
August 11, 2012
Granulocytes and vascularization regulate uterine bleeding and tissue remodeling in a mouse menstruation model
Astrid Menning, Alexander Walter, Marion Rudolph, et al.
British Journal of Clinical Pharmacology
|
April 19, 2022
First-in-human study of eliapixant (BAY 1817080), a highly selective P2X3 receptor antagonist: Tolerability, safety and pharmacokinetics
Stefan Klein, Isabella Gashaw, Sybille Baumann, et al.
Page
of 4